Newspaper cutting with regard to publication of unaudited financial results for the quarter ended on June 30, 2026, in Financial Express on August 12, 2026.

August 12, 2026 Listing Department Code: 532321 BSE LIMITED P J Towers, Dalal Street, Mumbai-400001 Listing Department Code: ZYDUSLIFE NATIONAL STOCK EXCHANGE OF INDIA LIMITED Exchange Plaza, C/1, Block G, Bandra Kurla Complex, Bandra (E), Mumbai-400051 Re.: Newspaper publication Ref.: Disclosure under regulation 30 read with regulations 33 and 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“the Listing Regulations”) Dear Sir / Madam, Pursuant to the provisions of regulation 30 read with regulations 33 and 47 of the Listing Regulations, please find attached the newspaper cutting with regard to publication of unaudited financial results for the quarter ended on June 30, 2026, in Financial Express on August 12, 2026. Please find the same in order. Thanking you, Yours faithfully, For, ZYDUS LIFESCIENCES LIMITED DHAVAL N. SONI COMPANY SECRETARY AND COMPLIANCE OFFICER MEMBERSHIP NO. FCS7063 Encl.: As above WWW.FINANCIALEXPRESS.CQ11 WEDNESDAY, AUGUST 12, 2026 Zydus Ufesclences Urn.ited Registered Offlce. Z¥dut Ccl'ponibt Pa~ Sdleme Nn. 6l, ~ No. 536, IOmJ (Gandhinagar), New~ Otde, 5artdk,J- H~ Ahmedabad • 382~!11 OtdioU!dToute Td . No.: (+91·79) .(80<! 0000 Website: www.zydusll~.alm ON" _l2-123DGJl995Pt(l)2S87D lbtract COmolldllt.ad Unaudrt.l Fln•ndaf Rasi.1119 for th• mir fnded J.une 30 2026 IHA MIier sided YUtt ended s,, No. 6 3 l 3 ~ 'JIJlOfi/2075 3J 026 (~ ed} (IJradt8II) (hdted) TOIII inm1• flan, q,eltl0rJS 80,170 75,870 65,7)7 :OJ,44 2 ltll llofk for IN Plfb' bdole mpOor'ill lttms IOd In J3.248 20..572 19,205 11;Jn J Nit p olll for !hi i,.1od llllf mllllCb~ h:!ma tu; bib:; l3JI 13.0(16 16,,597 19t20(i 156,111 4 Nft profit tor the pebd Jfts tu IOd ,u,...untn4,ig 111tmcst 9,398 l2)2S 14,668 S0,400 llDI ~ lnu:cl• for the perkid tCbl- in and ~ Jnteret 9,120 7,902 42,673 ~ equity lhlr1I apt.11 cr.oe ._ Re. 998 1,006 1,006 1,006 7 Olle equity 270,JOII bmll91 pf!r .,_.. (not, ,,.,. E A lbr ttle Q\l,Vtl!r) I ftr1C (IN'l) som 9.35 12.65 14.58 b tllutlll (ltlJQ 9.35 l2Ji5- 14.58 50.09 (I) llie abovol II en atrad of the dltllled format d Qun,1v An.indal Results fJll,d with the Stix.x E)d\ll)geS under Regulallan 33 or the SEBJ [Usllng ~tDIS and Dlsdosu-e Requlrerr,e111t11) ~ . 2015. The results, al0npwltl the Limited Review Repofb llf'e awtable cwi trie CllmpaJ1Y's ~ WWW,zYduslife.cotn, on the IIWltultiai .,, ase (www.lRlncb.cun) , ,., m the ~ .sit IX NSE fwww.,welndia.Qffll) l!IXf can also bo .., .,~ by SCill\nlng lhe fo&k,w1ng QR Code! 9y Order or 'the Bow, NY ZWt.11 I.If~U mlt.ed, Dc;Shan-iJ p, Porei Do: August ll, 2026 Ml~Olm:tcr Pllte; Nw•-rtalJld 0£N: OOJJl995 Zydus Lifesciences Limited Registered Office: Zydus Corporate Park, Scheme No. 63, Survey No. 536, Khoraj (Gandhinagar), Near Vaishnodevi Circle, Sarkhej-Gandhinagar Highway, Ahmedabad -382481 Dedicated To Life Tel. No.: (+91-79) 4804 0000 Website: www.zyduslife.com CIN : L24230GJ1995PLC025878 Extract of Consolidated Unaudited Financial Results for the Quarter Ended June 30, 2026 INR Million Quarter ended Year ended Sr. No. Particulars 30/06/2026 31/03/2026 30/06/2025 31/03/2026 (Unaudited) (Unaudited) (Unaudited) (Audited) 1 Total income from operations 80,170 75,870 65,737 271,484 2 Net profit for the period before exceptional items and tax 13,248 20,572 19,206 71,377 3 Net profit for the period after exceptional items but before tax 13,066 16,597 19,206 66,211 4 Net profit for the period after tax and non-controlling interest 9,398 12,725 14,668 50,400 5 Total comprehensive income for the period after tax and non-controlling interest 9,120 7,902 14,717 42,673 6 Paid-up equity share capital (Face value Re. 1/-) 998 1,006 1,006 1,006 7 Other equity 270,108 8 Earnings per share (not annualised for the quarter) a Basic (INR) 9.35 12.65 14.58 50.09 b Diluted (INR) 9.35 12.65 14.58 50.09 Note: [1] The above is an extract of the detailed format of Quarterly Financial Results filed with the Stock Exchanges under Regulation 33 of the SEBI [Listing Obligations and Disclosure Requirements] Regulations, 2015. The results, alongwith the Limited Review Reports are available on the Company's website: www.zyduslife.com, on the website of BSE [www.bseindia.com] and on the website of NSE [www.nseindia.com] and can also be accessed by scanning the following QR Code: .... ~ ...t t~~'\'· By Order of the Board, For Zydus Lifesciences Limited, Dr. Sharvil P. Patel Date: August 11, 2026 @; . ,[ -- t ;t~ . .. Managing Director Place: Ahmedabad DIN: 00131995